Detail of the clinical trial

Title of the trial A Phase I/II Pharmacokinetic Study of Intravenous and Oral Forodesine in Children with Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non- Hodgkin´s Lymphoma
EudraCT number 2008-002219-42
Protocol number BCX1777-108
Sponsor Mundipharma Research Limited, Cambridge, United Kingdom
Indications Hemato-oncology
Diagnosis Acute Lymphoblastic Leukemia
Population in clinical trial Children (2-11 years)
Adolescents (12-17 years)
Male
Female
Patients
Year of receiving the request to Institute (SÚKL) 2009
Date of approval by Institute (SÚKL) 22.1.2010
Date of approval by EC 13.1.2010
Date of initiation CT in ČR
Date of ending CT in ČR 14.10.2010
Notice
Sites Dětské oddělení, Univerzitní dětská nemocnice Brno
Oddělení dětské hematologie a onkologie, Univerzitní nemocnice Motol, Praha 5

‹‹ Back to list